Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function
- PMID: 11714985
- DOI: 10.1099/0022-1317-82-12-3067
Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function
Abstract
Co-operation between the Epstein-Barr virus (EBV)-coded leader protein EBNA-LP and the nuclear antigen EBNA2 appears to be critical for efficient virus-induced B cell transformation. Here we report the genetic analysis of EBNA-LP function using two transient co-transfection assays of co-operativity, activation of latent membrane protein 1 (LMP1) expression from a resident EBV genome in Akata-BL cells and activation of an EBNA2-responsive reporter construct. Small deletions were introduced into each of five conserved regions (CRs) of EBNA-LP sequence present in type 1 and type 2 EBV strains and in several primate lymphocryptovirus EBNA-LP homologues. Deletions within all three CRs in the EBNA-LP W1W2 repeat domain completely abrogated function, through inhibition of nuclear localization in the cases of CR1 and CR2 but not of CR3; deletions within CR4 and CR5 in the Y1Y2 unique domain had relatively little effect, yet loss of the whole Y2 sequence blocked activity. Alanine substitution of serine residues within potential phosphorylation sites identified two mutants of particular interest. Substitution of three such residues (S34,36,63) within W1W2 not only abrogated EBNA-LP activity but was associated with a complete loss of EBNA2 detectability in co-transfected cells, implying possible destabilization of the co-expressed EBNA2 protein. More importantly the individual substitution of S36 completely blocked EBNA-LP/EBNA2 co-operativity while retaining EBNA2 expression. We infer critical roles for the CR3 domain and for the S36 residue in EBNA-LP's co-operative function.
Similar articles
-
Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.J Virol. 2000 Nov;74(21):9953-63. doi: 10.1128/jvi.74.21.9953-9963.2000. J Virol. 2000. PMID: 11024123 Free PMC article.
-
Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.J Virol. 2000 Jan;74(1):379-89. doi: 10.1128/jvi.74.1.379-389.2000. J Virol. 2000. PMID: 10590127 Free PMC article.
-
Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.J Virol. 2002 Feb;76(3):1025-32. doi: 10.1128/jvi.76.3.1025-1032.2002. J Virol. 2002. PMID: 11773378 Free PMC article.
-
Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.J Virol. 1997 Sep;71(9):6619-28. doi: 10.1128/JVI.71.9.6619-6628.1997. J Virol. 1997. PMID: 9261384 Free PMC article.
-
EBNA2 and Its Coactivator EBNA-LP.Curr Top Microbiol Immunol. 2015;391:35-59. doi: 10.1007/978-3-319-22834-1_2. Curr Top Microbiol Immunol. 2015. PMID: 26428371 Review.
Cited by
-
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.J Virol. 2007 Sep;81(18):10092-100. doi: 10.1128/JVI.00358-07. Epub 2007 Jul 11. J Virol. 2007. PMID: 17626071 Free PMC article.
-
Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.J Virol. 2008 Aug;82(15):7456-66. doi: 10.1128/JVI.00223-08. Epub 2008 May 14. J Virol. 2008. PMID: 18480445 Free PMC article.
-
EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.Proc Natl Acad Sci U S A. 2011 May 10;108(19):7808-13. doi: 10.1073/pnas.1104991108. Epub 2011 Apr 25. Proc Natl Acad Sci U S A. 2011. PMID: 21518914 Free PMC article.
-
Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.J Virol. 2007 Jul;81(14):7598-607. doi: 10.1128/JVI.02435-06. Epub 2007 May 9. J Virol. 2007. PMID: 17494066 Free PMC article.
-
Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.J Virol. 2018 Apr 13;92(9):e02155-17. doi: 10.1128/JVI.02155-17. Print 2018 May 1. J Virol. 2018. PMID: 29467311 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Research Materials